Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS
M. Labopin , G. Meloni , A. van Biezen , R. Or
Blood 90 ( 10) 3853 -3857
98
1997
Outcomes of adults with active or progressive hematological malignancies at time of allogeneic stem cell transplantation : a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
M. Labopin , K. Bilger , M. Michallet , P. Chevallier
Bone Marrow Transplantation 49
2014
Machine learning based predictive modeling for mortality 100 days post allogeneic hematopoietic stem cell transplantation (ALLO-HSCT) in acute leukemia: an EBMT-acute leukemia working party (ALWP) registry study
M. Labopin , O. Bondi , J. Cornelissen , Frédéric Baron
Bone Marrow Transplantation 49
2014
Unrelated cord blood (ECB) transplantation for AML: higher incidence of acute GVHD and lower survival in male patients transplanted with female unrelated cord blood. A report from Eurocord and the ALWP of the EBMT
M. Labopin , A. Rambaldi , Frédéric Baron , A. Bosi
Bone Marrow Transplantation
2015
Exploring limiting factors in the prediction of allogeneic HSCT related mortality: an in-silico machine learning analysis of the acute leukemia working party (ALWP) registry of the EBMT
M. Labopin , Frédéric Baron , A. Nagler , M. Mohty
Bone Marrow Transplantation 50
2015
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
H. Esperou-Bourdeau , M. Labopin , G. Meloni , A. H. Goldstone
Bone Marrow Transplantation 18 ( 1) 111 -117
77
1996
Autologous bone marrow transplantation in 2502 patients with acute leukemia in Europe: a retrospective study.
M. Labopin , N. C. Gorin
Leukemia 6 95 -99
36
1992
How to study therapy dilemmas with respect to BMT
J. Hasford , S. Suciu , J. Hermans , M. Labopin
Bone marrow transplantation. Supplement 12 ( 4)
1993
Autologous bone marrow transplantation for childhood acute myeloid leukemia : a European survey
M. Labopin , E. Plouvier , P. Herve , P. Palut
Bone Marrow Transplantation 8 76 -79
9
1991
Mobilized peripheral blood stem cells compared with bone marrow for related reduced-intensity transplantation in acute myeloid leukaemia in complete remission: a retrospective analysis from the ALWP of EBMT
A Nagler , M Labopin , A Shimoni , G Mufti
Bone Marrow Transplantation 45
2010
Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission
M. Labopin , J. Reiffers , N. C. Gorin , M. Korbling
Bone Marrow Transplantation 7
3
1991
Winning Cord Blood Unit Characteristics Impacting on Outcomes after Double Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: a Collaborative Study of Eurocord and the Acute Leukemia Working Party of EBMT
M. Labopin , M. Michallet , P. Feugier , G. Socie
Bone Marrow Transplantation 51
2016
THIOTEPA-BASED CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) - A SURVEY FROM THE ALWP OF THE EBMT
S. Santarone , L. Kanz , D. Bunjes , M. Labopin
Bone Marrow Transplantation 49
2014
Impact of dose intensity on unrelated cord blood transplantation outcomes in adults patients with acute leukemia: A Report from Eurocord, the ALWP and the Cord Blood Committee of the CTIWP of the EBMT
M. Labopin , M. Michallet , G. Socie , J. Cornelissen
Bone Marrow Transplantation
1
2016
Comparison of haplo-identical versus unrelated allogeneic stem cell transplantation for acute myeloid leukemia with active disease: A report of 1578 patients from Acute Leukemia Working Party of EBMT
M. Labopin , M. Bornhäuser , J. Tischer , M. Stelljes
Bone Marrow Transplantation
2016
HLA disparities on unshared haplotype influence outcomes of unmanipulated haploidentical hematopoietic stem cell transplantation (HaploSCT): A Study from the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation (EBMT)
A. Ruggeri , W. Arcese , D. Blaise , K. Fleischhauer
Bone Marrow Transplantation
2016
Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT
S. Santarone , B. N. Savani , M. Labopin , J. Tischer
Haematologica
2017
Role of the graft-versus-leukaemia effect after reduced-intensity conditioning allogeneic stem cell transplantation as treatment for acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of the EBMT
F Baron , M Labopin , M Mohty , N Basara
Bone Marrow Transplantation 45
2010
Haematopoietic stem cell transplantation for sickle cell disease: an international survey on behalf of eurocord-monacord, EBMT paediatric disease working party and CIBMTR
V. Rocha , A. Ruggeri , S. Matthes , F. Locatelli
Bone Marrow Transplantation 49
2014
REDUCED INTENSITY (FB2) VS REDUCED TOXICITY MYELOABLATIVE (FB3-4) FLUDARABINE/BUSULFAN-BASED CONDITIONING REGIMENS FOR NON-HODGKIN LYMPHOMA (NHL) ALLOGRAFTED PATIENTS
A. Le Bourgeois , M. Labopin , D. Blaise , P. Ceballos
Hematological Oncology 35 193 -194
2017